Stocks were headed for weekly losses on Friday as investors worry the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
United Airlines will take its 14 Boeing 737 Max jets off its schedule for another month, through Aug. 3, canceling another 1,290 flights.Airlinesread more
Roughly three dozen House Democrats have called for impeachment hearings on President Donald Trump, a billionaire's TV ads rip the House for "doing nothing," and legal experts...Politicsread more
J.P. Morgan economists say they now see a much slower economy in the second quarter, with growth of just 1%.Market Insiderread more
If consummated, the deal would mark the latest in a flurry of activity in the payment technology space.Banksread more
The Pentagon will send additional American troops, drones and fighter jets to the Middle East amid increasing tensions between the United States and Iran.Politicsread more
Tobacco giant is nearing a deal to take a significant minority stake in e-cigarette company Juul that could come as soon as Thursday, people familiar with the situation tell CNBC.
Altria is set to take a 35 percent stake in Juul that would value the e-cigarette maker at $38 billion, the people said. The people familiar cautioned negotiations remain in flux. It is possible deal talks could extend beyond the next few weeks. It is also possible the deal falls part.
Should the deal be consummated, it would mark a turning point for Juul. The company has positioned itself as an , helping to wean adults off combustible cigarettes, which are responsible for killing about half a million Americans every year. But a surge in high school students using e-cigarettes, mainly Juul, has challenged that posture. It is widely thought these teens would have never smoked, but are being introduced to addictive nicotine by vaping.
U.S. regulators have cracked down on Juul's use of fruity flavors, which they say encourages teen use. With this pressure, Juul has started facing some of the same regulatory and financial pressures that Big Tobacco has dealt with for decades. A deal with Altria could bring that institutional knowledge.
In Juul's negotiations with Altria, it is seeking a number of conditions from the tobacco giant the could mitigate the potential reputation stain of selling a stake to a party it once labeled the enemy, the people familiar said. If successful, these conditions could mitigate some of the reputational stain that would come with selling a stake to a party it once labeled the enemy.
Some demands have included giving Juul top shelf space and adding Juul coupons to cigarette packs, the people said. Altria owns best-selling cigarette brand, Marlboro. It could not be immediately determined which if any of these stipulations Altria has or will agree to.
Should Altria announce a deal with Juul this month, it would be its second transformative investment in as many weeks. $1.8 billion for a 45 percent stake in Canadian cannabis company, . Altria also said as part of its Cronos announcement it will discontinue MarkTen and Green Smoke e-cigarette products, citing their financial performance combined with heightened regulatory restrictions. Outsiders viewed the move as clearing the way for Juul.
Both deals could provide Altria with new sources of revenue as its main business shrinks. Cigarette volumes have started declining faster than anticipated, threatening Altria's usual tactic of raising prices to offset the declines. That wouldn't be as big of an issue for Altria if it still profited when people switched to Juul pods from Marlboro cigarettes.
The people requested anonymity because the information is confidential.
Juul and Altria declined to comment. Altria has previously said it does not comment on speculation.